Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cochran

Showing results (231-240 of 997) with videos related to

Pageof 100
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1987
Bronchial anastomosis with a tissue adhesiveM Hachida, P Naruns, S Morris, et al.
International Journal of Cancer|August 15, 1983
Incidence and type of tumors induced by DMBA carcinogenesis in H-2 congenic strains on a B10 backgroundA Grönberg, A J Cochran, K Kärre, et al.
International Journal of Cancer|November 11, 1992
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneityS Kanda, A J Cochran, W R Lee, et al.
Melanoma Research|October 1, 1993
S-100 protein remains a practical marker for melanocytic and other tumoursA J Cochran, H F Lu, P X Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2007
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tellR A Scolyer, R Murali, J E Gershenwald, et al.
British Journal of Cancer|February 1, 1975
Proceedings: Immunity in patients with breast cancerA J Cochran, R M Mackie, C E Ross, et al.
Neurochemistry International|October 2, 2001
Pathological glial tau accumulations in neurodegenerative disease: review and case reportR W Berry, B Quinn, N Johnson, et al.
European Journal of Cancer|July 1, 1979
The mechanism of tumour cell induced inhibition of human leucocyte migrationC E Ross, A J Cochran, A M Jackson, et al.
Cancer|June 1, 1993
Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thicknessD L Morton, D G Davtyan, L A Wanek, et al.
International Journal of Cancer|November 15, 1981
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing CommitteeA J Cochran, M E Buyse, F J Lejeune, et al.
Pageof 100

Showing results (231-240 of 997) with videos related to

Sort By:
Pageof 100
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1987
Bronchial anastomosis with a tissue adhesiveM Hachida, P Naruns, S Morris, et al.
International Journal of Cancer|August 15, 1983
Incidence and type of tumors induced by DMBA carcinogenesis in H-2 congenic strains on a B10 backgroundA Grönberg, A J Cochran, K Kärre, et al.
International Journal of Cancer|November 11, 1992
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneityS Kanda, A J Cochran, W R Lee, et al.
Melanoma Research|October 1, 1993
S-100 protein remains a practical marker for melanocytic and other tumoursA J Cochran, H F Lu, P X Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2007
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tellR A Scolyer, R Murali, J E Gershenwald, et al.
British Journal of Cancer|February 1, 1975
Proceedings: Immunity in patients with breast cancerA J Cochran, R M Mackie, C E Ross, et al.
Neurochemistry International|October 2, 2001
Pathological glial tau accumulations in neurodegenerative disease: review and case reportR W Berry, B Quinn, N Johnson, et al.
European Journal of Cancer|July 1, 1979
The mechanism of tumour cell induced inhibition of human leucocyte migrationC E Ross, A J Cochran, A M Jackson, et al.
Cancer|June 1, 1993
Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thicknessD L Morton, D G Davtyan, L A Wanek, et al.
International Journal of Cancer|November 15, 1981
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing CommitteeA J Cochran, M E Buyse, F J Lejeune, et al.
Pageof 100